EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients

Inmaculada Serrano, Ana Luque, Alexandra Ruiz-Cerulla, Sergio Navas, Anna M Blom, Santiago Rodríguez de Córdoba, Francisco J Fernández, M Cristina Vega, Francisco Rodríguez-Moranta, Jordi Guardiola, Josep M Aran

Pharmacological Research · 2023

DOI: 10.1016/j.phrs.2023.106948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2023. Verfasst von Inmaculada Serrano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immune-inflammatory Processes and Gene Therapeutics Group, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, 08908 Ba…. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisInflammatory Bowel DiseasesAnimalsHumansMiceAnti-Inflammatory AgentsImmunomodulationInflammationMyeloid CellsHistocompatibility Antigens

Stichwörter der Autor:innen

Alpha-D-fructofuranosyl Alpha-D-glucopyranoside (PubChem CID: 3036169)Barium chloride (PubChem CID: 25204)C4BP(β-)DSS-colitisDextran sulfate sodium salt (PubChem CID: 2337)ImmunomodulationInflammationL-glutamine (PubChem CID: 5961)Minocycline hydrochloride (PubChem CID: 54685925)PRP6-HO7Sodium dodecyl sulfate (PubChem CID: 3423265)Triton X-100 (PubChem CID: 5590)

Substanzen

Anti-Inflammatory AgentsC4BPB protein, humanHistocompatibility AntigensC4bp protein, mouse

Autor:innen und Institutionen

  • Immune-inflammatory Processes and Gene Therapeutics Group, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Department of Digestive Diseases, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Structural Biology of Host-Pathogen Interactions Group, Centro de Investigaciones Biológicas Margarita Salas (CSIC), 28040 Madrid, Spain.
  • Lund University, Department of Translational Medicine, Section of Medical Protein Chemistry, 21428 Malmö, Sweden.
  • Molecular Pathology/Genetics of Complement Group, Centro de Investigaciones Biológicas Margarita Salas (CSIC) and Ciber de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.
  • Abvance Biotech SL, 28003 Madrid, Spain.

Zitieren

APA

Serrano, I., Luque, A., Ruiz-Cerulla, A., Navas, S., Blom, A. M., Rodríguez de Córdoba, S., Fernández, F. J., Cristina Vega, M., Rodríguez-Moranta, F., Guardiola, J., & Aran, J. M. (2023). C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients. Pharmacological Research. https://doi.org/10.1016/j.phrs.2023.106948

Vancouver

Serrano I, Luque A, Ruiz-Cerulla A, Navas S, Blom AM, Rodríguez de Córdoba S, et al. C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients. Pharmacological Research. 2023. doi:10.1016/j.phrs.2023.106948

BibTeX
@article{Serrano2023,
  author = {Serrano, Inmaculada and Luque, Ana and Ruiz-Cerulla, Alexandra and Navas, Sergio and Blom, Anna M and Rodríguez de Córdoba, Santiago and Fernández, Francisco J and Cristina Vega, M and Rodríguez-Moranta, Francisco and Guardiola, Jordi and Aran, Josep M},
  title = {C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients},
  journal = {Pharmacological Research},
  year = {2023},
  doi = {10.1016/j.phrs.2023.106948}
}
Kostenlos starten →